Contextual factors of implementing APOL1 genetic testing into living kidney donor clinical evaluation
Merle, J.-L.; Kuo, M.-C.; Gacki-Smith, J.; Agrawal, A.; Friedewald, J.; Gordon, E.-J.; Smith, J.-D. · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · 2025 · Heft 7 · S. 758 bis 768
Bibliografische Angaben
Zusammenfassung
Living donor kidney transplantation (LDKT) is the preferred treatment for patients with end-stage kidney disease, offering longer graft survival and improved quality of life. However, LDKT poses risks to living donors. Black living donors face disproportionately higher risks of postdonation kidney disease than White counterparts, necessitating deeper understanding of the factors contributing to this disparity. This study evaluated the implementation of the APOL1 Genetic Testing and Counseling Program at two transplant centers to improve donors’ informed decision-making, which entailed examining the contextual fa…
